By now, you've almost certainly heard of Ozempic and/or Wegovy - two weight loss drugs that have taken America by storm.
Both are trademarks for the same compound - semaglutide - which decreases appetite and slows down the emptying of the stomach. In short: they make you less hungry.
And while these drugs were designed to treat Type II Diabetes, they're now consumed by millions of folks who don't have Diabetes, but instead simply want to shed pounds.
Well, pharma giant Eli Lilly just announced it's getting in on the action with an even more powerful drug called Mounjaro (side bar: did they just merge "Mount" + "Kilimanjaro"?).
Users of Ozempic and Wegovy shed ~15% of their body weight over 16 months, whereas users of Mounjaro lost up to 22% over that period.
Is any of this good for society? Hard to say! I'm primarily a proponent of nutrition, sleep, and exercise, but I also can't ignore data.
"If everyone who's [overweight] lost 20% of their body weight, we'd be taking patients off reflux, diabetes, and hypertension medications," says Dr. Apovian, a director at the Center for Weight Management at Brigham and Women’s Hospital.
Again...tricky topic. Society needs more data to chart the best path vis-à-vis these drugs.
In any case, clean nutrition will always be your friend!